RHYTHM PHARMACEUTICALS, INC. (RYTM) › Shareholders' EquityRHYTHM PHARMACEUTICALS, INC. (RYTM) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2014: -$358.0K2015: -$8.00M2016: -$32.70M2017: $144.79M2018: $246.26M2019: $281.02M2020: $166.53M2021: $284.15M2022: $264.26M2023: $169.76M2024: $21.73M2025: $139.07M$139.07M2014Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$139.07M+540.0%2024$21.73M-87.2%2023$169.76M-35.8%2022$264.26M-7.0%2021$284.15M+70.6%2020$166.53M-40.7%2019$281.02M+14.1%2018$246.26M+70.1%2017$144.79M+542.7%2016-$32.70M-308.8%2015-$8.00M-2134.4%2014-$358.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share